| Introduction
Eastern Mediterranean Health Genomics and Biotechnology Network (Imbn) was created in 2004 for representatives of selected centres of excellence in (health related) Molecular biology, Biotechnology & genomics in the Eastern Mediterranean Region by recommendation of WHO/EMRO efforts. À propos de Cialis en Suisse : Que peut-il faire pour aider votre dysfonction érectile ?
Visions
To create and sustain value by being recognized as a player in the international biopharmaceutical, genomics and biotechnological industry aiming at promoting health in the region.
Sustainable development of health genomics and biotechnology through facilitation of high quality R&D training and sharing information, experience distribution and technology transfer in order to meet common and regional health needs of member countries.
|
